{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:51:59Z","timestamp":1794009119784,"version":"4.8.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:p>Urticaria is a common skin condition encountered across various specialties in medicine, especially in dermatology and allergy\/immunology practice. It has a heterogeneous presentation hence it is unsurprising that many skin conditions may be confused with urticaria. Urticaria may present as acute or chronic urticaria, the latter can be further categorised into chronic spontaneous and chronic inducible. In this article, we explore, explain, and summarise various skin lesions that are considered mimickers of urticaria, to promote understanding of each of the conditions highlighted, improve recognition, and reduce misdiagnosis.<\/jats:p>","DOI":"10.3389\/falgy.2023.1274031","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T05:25:36Z","timestamp":1695965136000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Urticaria and mimickers of urticaria"],"prefix":"10.3389","volume":"4","author":[{"given":"Jie Shen","family":"Fok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance H.","family":"Katelaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41572-022-00389-z","article-title":"Urticaria","volume":"8","author":"Kolkhir","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/all.15090","article-title":"The international EAACI\/GA2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"Zuberbier","year":"2022","journal-title":"Allergy"},{"key":"B3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.15586\/aei.v50iSP1.538","article-title":"Urticaria and angioedema in children and adolescents: diagnostic challenge","volume":"50","author":"Ensina","year":"2022","journal-title":"Allergol Immunopathol (Madrid)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1111\/all.13949","article-title":"Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: results of the PURIST study","volume":"74","author":"Schoepke","year":"2019","journal-title":"Allergy"},{"key":"B5","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.jaci.2017.10.035","article-title":"IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria","volume":"142","author":"Schmetzer","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1016\/j.jaip.2021.03.049","article-title":"The diagnostic workup in chronic spontaneous urticaria \u2013 what to test and why","volume":"9","author":"Metz","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B7","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/bjd.13567","article-title":"Paediatric mastocytosis: a systematic review of 1747 cases","volume":"172","author":"M\u00e9ni","year":"2015","journal-title":"Br J Dermatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jaci.2015.08.034","article-title":"Cutaneous manifestations in patients with mastocytosis: consensus report of the European competence network on mastocytosis; the American academy of allergy, asthma & immunology; and the European academy of allergology and clinical immunology","volume":"137","author":"Hartmann","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/bmj.2.455.323","article-title":"Rare forms of urticaria","volume":"2","author":"Nettleship","year":"1869","journal-title":"Br Med J"},{"key":"B10","first-page":"161","article-title":"An anomalous mottled rash, accompanied by pruritus, factitious urticaria and pigmentation, \u201curticaria pigmentosa(?).\u201d","volume":"11","author":"Sangster","year":"1878","journal-title":"Trans Clin Soc London"},{"key":"B11","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/his.14573","article-title":"Establishing diagnostic criteria for mastocytosis in skin biopsies","volume":"80","author":"Drabent","year":"2022","journal-title":"Histopathology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1111\/ced.15262","article-title":"Histopathological characteristics are instrumental to distinguish monomorphic from polymorphic maculopapular cutaneous mastocytosis in children","volume":"47","author":"Hermans","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2761.e1","DOI":"10.1016\/j.ajem.2020.05.084","article-title":"Herpes associated erythema multiforme: a retrospective study","volume":"38","author":"Hao","year":"2020","journal-title":"Am J Emerg Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.2147\/CCID.S408958","article-title":"Skin manifestations among patients admitted with COVID-19: a cross-sectional study at a university-based tertiary hospital in Jordan","volume":"16","author":"Alshiyab","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.7774\/cevr.2023.12.2.87","article-title":"Occurrence of erythema multiforme following COVID-19 vaccination: a review","volume":"12","author":"Yousefian","year":"2023","journal-title":"Clin Exp Vaccine Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e524","DOI":"10.1111\/jdv.18063","article-title":"Erythema multiforme in COVID-19 patients and following COVID-19 vaccination: manifestations, associations and outcomes","volume":"36","author":"Etaee","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1016\/j.vaccine.2019.12.028","article-title":"Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999\u20132017","volume":"38","author":"Su","year":"2020","journal-title":"Vaccine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1365-4632.2011.05348.x","article-title":"Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practising dermatologist","volume":"51","author":"Sokumbi","year":"2012","journal-title":"Int J Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1529-8019.2011.01395.x","article-title":"Approach to the hospitalized patient with targetoid lesions","volume":"24","author":"Hughey","year":"2011","journal-title":"Dermatol Ther"},{"key":"B20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.jaad.2019.02.057","article-title":"Triggers, clinical manifestations, and management of pediatric erythema multiforme: a systematic review","volume":"81","author":"Zoghaib","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0190-9622(83)80003-6","article-title":"Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes","volume":"8","author":"Huff","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jaci.2018.09.007","article-title":"Treatment of urticarial vasculitis: a systematic review","volume":"143","author":"Kolkhir","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/ced.12553","article-title":"A 14-year paraneoplastic rash: urticarial vasculitis and dermal binding bullous pemphigoid secondary to chronic lymphocytic leukaemia","volume":"40","author":"Kassim","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1365-2133.2007.07983.x","article-title":"Hypocomplementaemic urticarial vasculitis associated with non-Hodgkin lymphoma and treatment with intravenous immunologlobulin","volume":"157","author":"Shah","year":"2007","journal-title":"Br J Dermatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/01.dad.0000246646.45651.a2","article-title":"Cutaneous vasculitis update: small vessel neutrophilic vasculitis syndromes","volume":"28","author":"Carlson","year":"2006","journal-title":"Am J Dermatopathol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.jaci.2022.02.007","article-title":"Urticarial vasculitis: clinical and laboratory findings with a particular emphasis on differential diagnosis","volume":"149","author":"Marzano","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3389\/fiimu.2018.00639","article-title":"Complement activation in inflammatory skin diseases","volume":"9","author":"Giang","year":"2018","journal-title":"Front Immunol"},{"key":"B28","first-page":"340","article-title":"Hypocomplementaemia with cutaneous vasculitis and arthritis. Possible immune complex syndrome","volume":"48","author":"McDuffie","year":"1973","journal-title":"Mayo Clin Proc"},{"key":"B29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0190-9622(82)70139-2","article-title":"The clinical and histopathologic spectrums of urticarial vasculitis: study of forty cases","volume":"7","author":"Sanchez","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.4049\/jimmunol.148.5.1396","article-title":"Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus","volume":"148","author":"Wisnieski","year":"1992","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.autrev.2008.06.006","article-title":"Anti-C1q autoantibodies","volume":"7","author":"Kallenberg","year":"2008","journal-title":"Autoimmun Rev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1365-3083.2008.02089.x","article-title":"Complement component C1q and anti-C1q antibodies in theory and in clinical practice","volume":"67","author":"Potlukova","year":"2008","journal-title":"Scand J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.4049\/jimmunol.0803573","article-title":"Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells","volume":"183","author":"Bigler","year":"2009","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1016\/j.jaip.2020.05.031","article-title":"Chronic obstructive airway disease associated with hypocomplementemic urticarial vasculitis","volume":"8","author":"David","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B35","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/0190-9622(92)70069-R","article-title":"Urticarial vasculitis: a histopathologic and clinical review of 72 cases","volume":"26","author":"Mehregan","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.3390\/jcm9072131","article-title":"Kidney involvement in hypocomplementemic urticarial vasculitis syndrome \u2013 a case-based review","volume":"9","author":"Ion","year":"2020","journal-title":"J Clin Med"},{"key":"B37","first-page":"409","article-title":"Crescentic glomerulonephritis complicating the course of hypocomplementemic urticarial vasculitis","volume":"54","author":"Messiaen","year":"2000","journal-title":"Clin Nephrol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e12031","DOI":"10.1002\/clt2.12031","article-title":"A novel histopathological scoring system to distinguish urticarial vasculitis from chronic spontaneous urticaria","volume":"11","author":"Puhl","year":"2021","journal-title":"Clin Transl Allergy"},{"key":"B39","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2340\/00015555-2233","article-title":"Urticaria and prodromal symptoms including erythema marginatum in Danish patients with hereditary angioedema","volume":"96","author":"Rasmussen","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/ced.12285","article-title":"Characterisation of prodromal symptoms in a large population of patients with hereditary angioedema","volume":"39","author":"Magerl","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"100511","DOI":"10.1016\/j.waojou.2021.100511","article-title":"Survey of actual conditions of erythema marginatum as a prodromal symptom in Japanese patients with hereditary angioedema","volume":"14","author":"Ohsawa","year":"2021","journal-title":"World Allergy Organ J"},{"key":"B42","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1126\/science.148.3672.957","article-title":"Hereditary angioneurotic edema: two genetic variants","volume":"148","author":"Rosen","year":"1965","journal-title":"Science"},{"key":"B43","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0140-6736(00)02483-1","article-title":"Hereditary angioedema with normal C1-inhibitor activity in women","volume":"356","author":"Bork","year":"2000","journal-title":"Lancet"},{"key":"B44","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/all.13270","article-title":"Hereditary angioedema with a mutation in the plasminogen gene","volume":"73","author":"Bork","year":"2018","journal-title":"Allergy"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.jaci.2017.05.020","article-title":"Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema","volume":"141","author":"Bafunno","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1111\/all.13869","article-title":"Hereditary angioedema cosegregating with a novel kininogen 1 gene mutation changing the N-terminal cleavage site of bradykinin","volume":"74","author":"Bork","year":"2019","journal-title":"Allergy"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1111\/all.14454","article-title":"A myoferlin gain-of-function variant associates with a new type of hereditary angioedema","volume":"75","author":"Ariano","year":"2020","journal-title":"Allergy"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.jaci.2021.01.011","article-title":"Novel hereditary angioedema linked with a heparan sulfate 3-O-sulfotransferase 6 gene mutation","volume":"148","author":"Bork","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archderm.142.1.29","article-title":"Defining urticarial dermatitis: a subset of dermal hypersensitivity reaction pattern","volume":"142","author":"Kossard","year":"2006","journal-title":"Arch Dermatol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1067\/mjd.2002.120908","article-title":"The clinical and histopathologic spectrum of \u201cdermal hypersensitivity reactions\u201d, a nonspecific histologic diagnosis that is not very useful in clinical practice, and the concept of a \u201cdermal hypersensitivity reaction pattern\u201d","volume":"47","author":"Fung","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s40257-017-0264-2","article-title":"Bullous pemphigoid: a review of its diagnosis, associations and treatment","volume":"18","author":"Bernard","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.det.2011.03.010","article-title":"Clinical features and practical diagnosis of bullous pemphigoid","volume":"29","author":"Schmidt","year":"2011","journal-title":"Dermatol Clin"},{"key":"B53","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1001\/jamadermatol.2018.5049","article-title":"Assessment of the prevalence of mucosal involvement in bullous pemphigoid","volume":"155","author":"Kridin","year":"2019","journal-title":"JAMA Dermatol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jaad.2019.04.029","article-title":"Nonbullous pemphigoid: insights in clinical and diagnostic findings, treatment responses, and progress","volume":"81","author":"Lamberts","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jaad.2022.04.029","article-title":"Bullous pemphigoid: three main clusters defining 3 outcome profiles","volume":"87","author":"Guerrois","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/1346-8138.15251","article-title":"Role of BP230 autoantibodies in bullous pemphigoid","volume":"47","author":"Shih","year":"2020","journal-title":"J Dermatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jdermsci.2007.08.008","article-title":"Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid","volume":"49","author":"Ishiura","year":"2008","journal-title":"J Dermatol Sci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/dth.12078","article-title":"Specific dermatoses of pregnancy and their treatment","volume":"26","author":"Lehrhoff","year":"2013","journal-title":"Dermatol Ther"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2023.1274031\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T05:25:40Z","timestamp":1695965140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2023.1274031\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":58,"alternative-id":["10.3389\/falgy.2023.1274031"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2023.1274031","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]},"article-number":"1274031"}}